Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 447
Selected: 0
NCT IDTitle
NCT04306926A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer
NCT06566248A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
NCT04574284A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
NCT06408285A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects
NCT05130515Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.
NCT04955834A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
NCT07482592Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT04056572Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
NCT02108756Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
NCT06448273A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects
NCT05718167TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.
NCT05068206A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
NCT05489276Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
NCT06860971A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT07266116Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
NCT05987358A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT07509892A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
NCT06768632Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State
NCT07147946Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT06160895A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
NCT04412577A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies
NCT06700395A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT03527888Study of Anlotinib in Patients With Primary Malignant Bone Tumors
NCT03059797Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)
NCT05859373To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
NCT03986073Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus
NCT06706310Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection
NCT04523285A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics
NCT06388759TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
NCT06429397Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
NCT05494060XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT04373395Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT04275583A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
NCT01874873A Phase II Study of Anlotinib in MTC Patients
NCT01940731Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NCT04234607A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)
NCT06165809A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
NCT05559242Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients
NCT06106841TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
NCT05375461TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail
NCT05262101Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma
NCT01924195Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302)
NCT02403544Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
NCT05033587Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
NCT03766490Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer
NCT04275050A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
NCT06452706The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
NCT05646758A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects